SA has committed R1.3 billion to roll out Lenacapavir, a twice-yearly HIV prevention injection, in a major push to reduce new ...

The Gauteng health department has begun a phased rollout of Lenacapavir, a twice-yearly HIV prevention injection now ...

South Africa recently launched Lenacapavir, an injection aimed at preventing HIV, which continues to take millions of lives ...

Add Yahoo as a preferred source to see more of our stories on Google. Lenacapavir is now approved to prevent HIV infection as well as to treat certain infections. - Gilead Sciences Inc. A drug ...

The Lenacapavir injections were compared to the current standard of HIV prevention—a pill called Truvada or Descovy taken ...

The ministry of Health says demand for Lenacapavir, the newly introduced twice-yearly HIV prevention injection, has exceeded ...

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a series of vaccines can coax the immune system to produce powerful antibodies ...

Describing it as an “historic turning point in South Africa’s national healthcare”, President Cyril Ramaphosa on Friday ...

Yeztugo, a twice-yearly shot, could be the catalyst for stopping a recent spike in new HIV diagnoses. It's now available in ...

Selected clinics across Gauteng are now offering a new HIV prevention option aimed at reducing new infections among high-risk ...

We look at how lenacapavir, a groundbreaking HIV prevention injection, is set to transform the fight against HIV and why it ...